News

Medically reviewed by Mary Choy, PharmD Some people who take Ozempic (semaglutide)—a drug for diabetes management and weight ...
Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...
The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...
Weight loss injections work by making you feel fuller and less hungry. There are plenty of weight loss medication options to ...
Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.
Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...
The Danish drugmaker, which makes Ozempic and Wegovy ... Eli Lilly is developing new weight-loss drugs, including a daily pill, that are expected to set up years of blockbuster sales for the ...
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.